ONC BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is $2.87 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.2% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About BeOne Medicines Ltd.
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Charts powered in part by Lightweight Charts™ by TradingView.